Skip to content

Evaluation of a new technology to treat urinary incontinence in women

Evaluation of a new technology to treat urinary incontinence in women: a single blind randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN74508432
Enrollment
200
Registered
2011-09-20
Start date
2009-05-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary incontinence Urological and Genital Diseases Other specified urinary incontinence

Interventions

All women are supplied with the same magazine article outlining current self help treatment for urinary incontinence. The women in the novel stimulation device group are supplied with enough single

Sponsors

Femeda Ltd (UK)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: All women: 1. Who suffer from stress incontinence 2. Who self refer 3. Who are interested in participating in the study

Exclusion criteria

Exclusion criteria: 1. Age under 18 years or more than 65years 2. Lack of consent to stimulation 3. Pregnancy 4. Implanted pacemaker 5. Recent pelvic surgery (within last 3 months) 6. Recent haemmorhage / haematoma / tissue damage 7. Previous or at presently undergoing any active therapy for pelvic malignancy 8. Urinary tract infection 9. Vaginal infection 10. Atrophic vaginitis 11. Diabetes or neurological condition 12. Any lesions or other pathology of the vagina or labia 13. Manual dexterity insufficient to place the device 14. Previously had treatment for their urinary incontinence 15. Refusal to provide permission for general practitioner (GP) examination 16. GP determination that the patient is not suitable for participation in the investigation 17. Had baby within the previous 3 months

Design outcomes

Primary

MeasureTime frame
Quality of life measured at week 2, weeek 4 and week 12 through completion of the short form version of the International Consultation on Incontinence Questionnaire (ICIQ-UI)

Secondary

MeasureTime frame
1. Patient Global Impression of Severity and of Improvement 2. Sexual dysfunction questionnaire (ICIQ-FLUTSex) 3. Diary of stimulation use and compliance Measured at week 2, weeek 4 and week 12

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026